Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms
Kathryn G. Schuff, … , Sylvia L. Asa, Malcolm J. Low
Kathryn G. Schuff, … , Sylvia L. Asa, Malcolm J. Low
Published October 1, 2002
Citation Information: J Clin Invest. 2002;110(7):973-981. https://doi.org/10.1172/JCI15912.
View: Text | PDF
Article Genetics

Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms

  • Text
  • PDF
Abstract

Research Article

Authors

Kathryn G. Schuff, Shane T. Hentges, Michele A. Kelly, Nadine Binart, Paul A. Kelly, P. Michael Iuvone, Sylvia L. Asa, Malcolm J. Low

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Effect of PRL treatment on lactotroph proliferation in primary pituitary...
Effect of PRL treatment on lactotroph proliferation in primary pituitary cultures. Primary cultures were treated with increasing concentrations of mPRL. The proliferative index was calculated as the percentage of cells demonstrating immunoreactivity for both PRL and BrdU relative to the total number of PRL-immunoreactive cells. (a) PRL treatment reduced the proliferative index by a maximum of 75% in pituitary cultures from wild-type female mice. (b) PRL treatment had no effect on the lactotroph proliferative index in cultures from Drd2–/– female mice. (c) PRL treatment reduced the proliferative index by a maximum of 73% in pituitary cultures from Drd2–/– male mice. P < 0.001 for ANOVA of main effect of PRL treatment for wild-type female and Drd2–/– male pituitary cultures. *P < 0.001 compared with control medium without recombinant PRL by Fisher post hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts